Medicine compounds containing isosorbide mononitrate for treating high blood pressure

A technology of isosorbide dinitrate and composition, which is applied in the field of new pharmaceutical compositions, can solve problems such as increased pulse pressure, achieve the effects of reducing systolic blood pressure and pulse pressure difference, reducing arterial pressure, and lowering blood pressure

CN101229375BActive Publication Date: 2010-06-16LUNAN PHARMA GROUP CORPORATION
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2010-06-16
Patent Text Reader

Abstract

The invention provides a medical composite which consists of isosorbide mononitrate and epinephrines receptor blocker. Experimental results reveal that isosorbide mononitrate and epinephrines receptorblocker can achieve quite good synergistic effect on reducing blood pressure and preventing hypertension complications. The medical composite provided by the invention can effectively prevent the organ from being damaged by hypertension and improve the long-term survival rate of hypertension sufferers.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] This application is a divisional application of the patent application with the application number 200510125589.9 and the invention name "Pharmaceutical Composition Containing Isosorbide Mononitrate for Treating Hypertension" filed on November 23, 2005.

[0002] The invention belongs to the medical technology and relates to a new pharmaceutical composition for the treatment of elderly hypertension. Background technique

[0003] New developments in the theory of drug therapy for hypertension

[0004] In the treatment of hypertensive patients, paying attention to whether the long-term survival rate of patients has been significantly improved is a great progress in the theory of hypertension treatment in recent years. Previously, it was thought that diastolic blood pressure (DBP) was a better indicator to determine the severity of hypertension, and the goal of drug treatment was to reduce DBP to less than 90, 85 or 80mmHg. Systolic blood pressure (SBP) ...

Examples

Embodiment 1

[0019] Isosorbide Mononitrate Nitrendipine Extended Release Tablets

[0020] Prescription A

[0021] Isosorbide Mononitrate 15g

[0022] Starch 50g

[0023] L--HPC 20g

[0024] 10% starch slurry appropriate amount

[0025] Magnesium Stearate 1g

[0026] Prescription B

[0027] Nitrendipine 15g

[0028] HPMC--4M 20g

[0029] HPMC--15M 30g

[0030] Microcrystalline Cellulose 20g

[0031] PVP 8g

[0032] Micronized silica gel 35g

[0033] 8% PVPk30 absolute ethanol solution appropriate amount

[0034]Magnesium Stearate 2g

[0035] Preparation Process:

[0036] Pass isosorbide mononitrate, starch and L--HPC in prescription A through a 100-mesh sieve, mix well, add 10% starch slurry to granulate, dry below 50°C, granulate through a 18-mesh sieve, add stearin Magnesium acid mixed; pass nitrendipine, HPMC--4M, HPMC--15M, microcrystalline cellulose, PVP, and micropowder silica gel in prescription B through a 100-mesh sieve, mix well, add 8% PVPk30 absolute ethanol soluti...

Embodiment 2

[0038] Isosorbide Mononitrate Captopril Tablets

[0039] Isosorbide Mononitrate 10g

[0040] Captopril 50g

[0041] Starch 60g

[0042] Microcrystalline Cellulose 100g

[0043] L-HPC 30g

[0044] 10% starch slurry appropriate amount

[0045] Magnesium Stearate 2g

[0046] Preparation Process:

[0047] Pass the isosorbide mononitrate, captopril, starch, microcrystalline cellulose and L-HPC in the prescription through a 100-mesh sieve respectively, mix well, add 10% starch slurry to granulate in an appropriate amount, dry below 50°C, and dry for 18 Mesh sieve for granulation, add prescription amount of magnesium stearate, mix evenly, and compress into tablets.

Embodiment 3

[0049] Isosorbide Mononitrate Nifedipine Extended Release Tablets

[0050] Prescription A

[0051] Isosorbide Mononitrate 20g

[0052] Starch 100g

[0053] Sodium carboxymethyl starch 10g

[0054] 10% starch slurry appropriate amount

[0055] Magnesium Stearate 1g

[0056] Prescription B

[0057] Nifedipine 15g

[0058] Cetyl Alcohol 10g

[0059] Glyceryl monostearate 20g

[0060] Microcrystalline Cellulose 40g

[0061] 8% PVPk30 absolute ethanol solution appropriate amount

[0062] Magnesium Stearate 2g

[0063] Preparation Process:

[0064] Pass the isosorbide mononitrate, starch, and sodium carboxymethyl starch in prescription A through a 100-mesh sieve, mix well, add 10% starch slurry to granulate, dry below 50°C, granulate with a 18-mesh sieve, add hard Magnesium stearate and mix well; pass the nifedipine, cetyl alcohol, glyceryl monostearate and microcrystalline cellulose in prescription B respectively through a 100-mesh sieve, mix well, add 8% PVPk30 absolut...